Very long-term outcomes after a single catheter ablation procedure for the treatment of atrial fibrillation-the protective role of antiarrhythmic drug therapy.
João MesquitaDiogo CavacoAntónio Miguel FerreiraFrancisco Moscoso CostaPedro CarmoFrancisco MorgadoMiguel MendesPedro AdragãoPublished in: Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing (2018)
Half the patients remained free from AF 5 years after a single procedure. Female sex, non-paroxysmal AF, and LA volume/BSA independently predicted recurrence, whereas continuing AAD after the 3-month blanking period reduced relapse. In a multicenter registry of AF patients undergoing a first PVI, 57% relapsed over a median 5-year follow-up. Female sex, non-paroxysmal AF and LA volume/BSA were identified as independent predictors of relapse. Maintaining AAD therapy after the blanking period was associated with a long-term reduction in AF relapse.
Keyphrases
- atrial fibrillation
- catheter ablation
- left atrial
- left atrial appendage
- oral anticoagulants
- free survival
- direct oral anticoagulants
- patients undergoing
- heart failure
- end stage renal disease
- percutaneous coronary intervention
- peritoneal dialysis
- newly diagnosed
- minimally invasive
- acute myeloid leukemia
- acute lymphoblastic leukemia
- stem cells
- cross sectional
- prognostic factors
- patient reported outcomes
- drug induced
- diffuse large b cell lymphoma
- replacement therapy
- mitral valve
- electronic health record